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Available online 23 February 2016Introduction: Climate change and rapid population ageing are signiﬁcant public health challenges. Understanding
which health problems are affected by temperature is important for preventing heat and cold-related deaths and
illnesses, particularly in the elderly. Here we present a systematic review and meta-analysis on the effects of
ambient hot and cold temperature (excluding heat/cold wave only studies) on elderly (65+ years) mortality
and morbidity.
Methods: Time-series or case-crossover studies comprising cause-speciﬁc cases of elderlymortality (n=3,933,398)
or morbidity (n = 12,157,782) were pooled to obtain a percent change (%) in risk for temperature exposure on
cause-speciﬁc disease outcomes using a random-effects meta-analysis.
Results: A 1 °C temperature rise increased cardiovascular (3.44%, 95% CI 3.10–3.78), respiratory (3.60%, 3.18–4.02),
and cerebrovascular (1.40%, 0.06–2.75) mortality. A 1 °C temperature reduction increased respiratory (2.90%,
1.84–3.97) and cardiovascular (1.66%, 1.19–2.14) mortality. The greatest risk was associated with cold-induced
pneumonia (6.89%, 20–12.99) and respiratory morbidity (4.93% 1.54–8.44). A 1 °C temperature rise increased
cardiovascular, respiratory, diabetes mellitus, genitourinary, infectious disease and heat-related morbidity.
Discussion: Elevated risks for the elderly were prominent for temperature-induced cerebrovascular, cardiovascular,
diabetes, genitourinary, infectious disease, heat-related, and respiratory outcomes. These risks will likely increase
with climate change and global ageing.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Meta-analysis1. Introduction
Ambient temperature increase is an important public health con-
cern, associated with substantial death and illness (Basu and Samet,
2002a). Globally, the average temperature increased by 0.85 °C between
1880 and 2012 (IPCC, 2013). Across most land areas, projections indi-
cate an increase in the magnitude and frequency of hot days in the
late 21st century (IPCC, 2013). Furthermore, across many regions, low
temperatures also contribute greatly to the current burden from total
mortality (Gasparrini et al., 2015). Understanding the health risks asso-
ciated with high and low temperatures on elderly people is vital for
preventing heat and cold-related deaths and illnesses in this vulnerable
population (Basu et al., 2005). Elderly vulnerability is attributable toch, University of Heidelberg,
ker).
. This is an open access article underphysiological and social factors, including; living alone, multiple co-
morbidities and high medication use, slow physiological adaptation
and behavioural response to thermal stress, limited access to medical
care and housing with heating or cooling.
Forecasts predict an unprecedented rate of population ageing driven
by lengthening life expectancy, particularly in urban areas. The 60+age
group is expected to comprise 21.1% of the population by 2050 (United
Nations, 2013). As people live longer, the global burden of chronic and
degenerative disease will increase. The predominant contributors to
the global burden of disease in the elderly are cardiovascular disease,
malignant neoplasms, chronic respiratory diseases,musculoskeletal dis-
eases and neurological and mental diseases (Prince et al., 2015).
Two recent reviews describe temperature effects on elderly people's
health. Ameta-analysis by Yu et al. report greater elderly risk (65+) for
all-cause heat-relatedmortality (2–5%per 1 °C increase in temperature)
compared to all-cause cold-induced mortality in the 50+ age group
(1–2% per 1 °C decrease in temperature) (Yu et al., 2012). The review ofthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Descriptive study characteristics. Unique study ID corresponds to locations on Fig. 2. Exposure abbreviations: Temperature=T,Maximim=Max,Minimum=Min, Apparent Daily temp ature=ADT,Mean Daily Temperature=MDT, Universal Ther-
mal Climate Index (UTCI), Diurnal Temperature Range (DTR), PET index, (temperature, humidity, mean radiant temperature, wind speed). Additional information: RR= relative risk, CI= conﬁdence interval, Threshold t= Threshold temperature, se=
standard error. References to individual studies are listed in Supplementary ﬁle 2 (S2). Disease abbreviations: Subarachnoid haemorrhage (SAH), Intracerebral haemorrhage (IntH), Ha orrhagic stroke (HS), Cerebral infarction/Ischemic stroke (IS),
Other CBD (other CBD), Stroke (unspeciﬁed as haemorrhage or infarction) (Stroke), Cerebrovascular disease (CBD), Essential hypertension (Hypertension), Ischemic heart disease (IHD Angina (Angina), Myocardial infarction (MI), Aneurysm (Aneu-
rysm), Pulmonary embolism (PulEmb), Heart failure (HF), Coronary atherosclerosis (CorAth), Atrio-ventricular conduction disorders (AVCD), Cardiac arrhythmias (Arrhyt), Atrial Fibril ion (AtrFib), Pulmonary heart disease (PulHD), Sudden cardiac
death (SuddCD), Hypotension (Hypotension), Cardiovascular disease (CVD), Inﬂuenza and pneumonia (Flu-Pneu), Respiratory infections (InfResp), Asthma (Asthma), COPD and chroni ronchitis (COPD), Chronic lower respiratory diseases (COPD+
Asthma) (CLRD), Respiratory disease (RD), Cardio-respiratory disease (Cardio-Resp), Kidney stone (KidStone), Acute renal failure (AcuteRen), Renal/genitourinary disease (GUM), Gast enteritis (Gastro), Intestinal infection (IntInf), Infectious disease
(meningitis+other inﬂamatory diseases) (ID), Diabetesmellitus (Diab), Endocrine diseases (Endocr), Organicmental disorders (Demen), Psychoactive substance use (Psyco), Schizophre a (Schizo),Mental diseases (Mental), Extra-pyramidal disorders
(Park), Other disorders of the nervous system (DegDis), Nervous systemdiseases (Nervous), Digestive systemdiseases (Dig), Dehydration (Dehyd), Heatstroke (HStroke), Heat related dis se (Heat). 13 publications are only part of the systematic review
and not themeta-analysis: IDs 4,11,23,27,29,34 apply DTR as the exposure. ID 36 presents a non-linear risk at a threshold temperature, which is not comparable to per 1 °C change in tem rature. IDs 56–61 present a risk estimate as a comparison of two
temperatures, also not comparable to per 1 °C change in temperature.
Author, year ID Location Time-series Heat and/or
cold effect
Exposure Mortality or
morbidity
Disease outcome and elderly age Additional
information
Harlan, 2014 1 Arizona, USA 2000–2008 Heat Max ADT Mortality Heat, CVD, COPD/Asthma (65+) Clariﬁed this is not a heatwave paper, sample size
Burkart, 2014 2 26 regions, Bangladesh 2003–2007 Heat UTCI Mortality CVD, ID (65+) RR, 95% CI
Huang, 2014 3 Changsha, China 2008–2011 Heat MDT Mortality CVD (65+) No
Yang, 2013 4 Guangzhou, China 2003–2010 Heat and cold DTR Mortality CVD, RD (65+) Sample size, threshold t
Almeida, 2013 5 Lisbon and Oporto, Portugal 2000–2004 Heat Max ADT Mortality CVD, RD (65+) No
Gasparrini, 2012 6 England and Wales 1993–2006 Heat Max DT Mortality CBD, IHD, MI, ChIHD, PulHD, AVCD, AtrFib, Ar yt,
HeartFail, CVD, InfResp, COPD, PulHD, Asthma D,
Diab, Endocr, Demen, Schizo, Mental, Park, De is,
Nervous, GUM, Renal (65+)
No
Liu, 2011 7 Beijing, China 2003–2005 Heat and cold 2-day or 15-day Mean T Mortality CBD, IHD, CVD, RD, Cardio-Resp (65+) No
Wichmann, 2011 8 Copenhagen, Denmark 1999–2006 Heat and cold Max ADT Mortality CVD, CBD, RD (66+) No
Yu, 2011 9 Brisbane, Australia 1996–2004 Heat and cold MDT Mortality CVD (65+) No
Almeida, 2010 10 Lisbon and Oporto, Portugal 2000–2004 Heat Mean ADT Mortality CVD, RD (65+) No
Tam, 2009 11 Hong Kong 1997–2002 Heat DTR Mortality CVD (65+) No
Revich, 2008 12 Moscow, Russia 2000–2005 Heat and cold MDT Mortality IHD, CBD, CLRD (75+) No
Baccini, 2008 13 15 European cities 1990–2000 Heat Max ADT Mortality CVD, RD (65+) B-estimate, se, sample size, threshold t
Ishigami, 2008 14 Budapest, London and Milan 1993–2004 Heat MDT Mortality CVD, RD (75+) No
Gouveia, 2003 15 Sao Paulo, Brazil 1991–1994 Heat and cold MDT Mortality CVD, RD (65+) Sample size
Wong, 2014 16 Hong Kong 2001–2005 Cold MDT Mortality RD in patients with existing hypertension (65 ) Lag, threshold t
Xu, 2013 17 Hong Kong 1998–2001 Cold Mean ADT Mortality CVD, RD (65+) No
Analitis, 2008 18 15 European cities 1990–2000 Cold Min ADT Mortality CVD, CBD, RD (65+) RR, CI, sample size
Carder, 2005 19 3 regions, Scotland 1981–2001 Cold MDT Mortality CVD, RD (65+) Sample size
Cagle, 2005 20 Washington, USA 1980–2001 Cold MDT Mortality CVD (55+) No
Condemi, 2015 21 Cuneo, Italy 2007–2010 Heat MDT Morbidity KidStone (65+) No
Han, 2015 22 Seoul, South Korea 2004–2013 Heat Monthly MDT Morbidity CBD, IS, IntH (60+) No
(continued on next page)
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Table 1 (continued)
Author, year ID Location Time-series Heat and/or
cold effect
Exposure Mortality or
morbidity
Disease outcome and elderly age Additional
information
Li, 2014 23 Ghangzhou, China 2010–2012 Heat DTR Morbidity InfResp (65+) No
Kim 2014 24 Seoul, South Korea 2007–2010 Heat and cold MDT Morbidity Asthma (65+) No
Giang, 2014 25 Thai Nguyen, Vietnam 2008–2012 Heat and cold MDT Morbidity CVD (60+) No
Anderson, 2013 26 213 USA counties 1999–2008 Heat MDT Morbidity COPD, RD (65+) No
Wang, 2013 27 Beijing, China 2009–2011 Heat DTR Morbidity CVD, RD, Renal, Dig (65+) No
Chan, 2013 28 Hong Kong 1998–2009 Heat and cold MDT Morbidity RD, ID (60+) Sample size
Qiu, 2013 29 Hong Kong 2000–2007 Heat DTR Morbidity HF (65+) No
Wichmann, 2013 30 Gothenburg, Sweden 1985–2010 Heat Max ADT Morbidity AMI (66+) No
Williams, 2012 31 Adelaide, Australia 2003–2009 Heat Min DT Morbidity Renal, heat (65+) No
Goggins, 2012 32 Hong Kong 1999–2006 Heat and cold MDT Morbidity IS (65+) Sample size
Wichmann, 2012 33 Copenhagen, Denmark 1999–2006 Heat and cold Max ADT Morbidity AMI (66+) No
Lim, 2012 34 4 cities, South Korea 2003–2006 Heat DTR Morbidity Asthma (75+) No
Basu 2012 35 California, USA 2005–2008 Heat Mean ADT Morbidity CVD, Arrhyt, Aneurysm, IHD, Hypertension, HS, IS,
Hypotension, RD, AcuteRen, Hstroke, IntInf, Diab,
Dehyd (65+)
RR, CI, sample size
Vida, 2012 36 3 regions in Quebec, Canada 1995–2007 Heat MDT Morbidity Mental (65+) Clariﬁed effect is not per 1 °C increase in temperature
Silva, 2012 37 Sao Paulo, Brazil 2003–2007 Heat and cold Max DT Morbidity CVD, RD (60+) RR, CI
Alessandrini,
2011
38 9 regions Emilia-Romagna, Italy 2002–2006 Heat and cold Mean ADT Morbidity CVD, RD (65+) No
Pudpong, 2011 39 Chang Mai, Thailand 2002–2006 Heat MDT Morbidity RD, CVD, Diab, IntInf (65+) Sample size
Morabito, 2011 40 Tuscany, Italy 1997–2006 Heat and cold MDT Morbidity SAH, IntH, IS, Stroke (65+) No
Hopstock, 2011 41 Tromso, Norway 1974–2004 Heat 3-day Mean T Morbidity MI (65+) Sample size
Wichmann, 2011 42 Copenhagen, Denmark 2002–2006 Heat and cold Max ADT Morbidity RD, CVD, CBD (66+) No
Green, 2010 43 California, USA 1999–2005 Heat Mean ADT Morbidity Flu-Pneu, IS, Dehyd, Gastro, Diab, AcuteRen (65+) RR, CI, sample size
Lin, 2009 44 New York, USA 1991–2004 Heat Mean ADT Morbidity CVD, RD (50+) CI, sample size
Michelozzi, 2009 45 12 European cities 1990–2001 Heat Max ADT Morbidity CVD, CBD, RD (65+) No
Linares, 2008 46 Madrid, Spain 1995–2000 Heat Max DT Morbidity RD (75+) No
Kovats, 2004 47 London, UK 1994–2000 Heat MDT Morbidity RD (65+) Sample size
Koken, 2003 48 Denver, USA 19,931,997 Heat Max DT Morbidity AMI, CorAth, PulHD, Arrhyt, HF (65+) No
Liu, 2014 49 Shanghai, China 2008–2011 Cold MDT Morbidity Flu-Pneu (65+) No
Vasconcelos, 2013 50 Lisbon and Opoto, Portugal 2003–2007 Cold PET index Morbidity CVD, AMI (65+) No
Bhaskaran, 2010 51 England and Wales 2003–2006 Cold MDT Morbidity MI (65+) Sample size
Ebi, 2004 52 3 cities, California, USA 1983–1998 Cold Max DT Morbidity CBD, AMI, Angina, HF (55+) No
Hong 2003 53 Incheon, Korea 1998 2000 Cold MDT Morbidity IS (65+) No
Hajat, 2002 54 London, UK 1992–1995 Cold MDT Morbidity RD, Asthma, Lower RD, Upper RD, CVD (65+) No
Ebi, 2001 55 3 cities, California, USA 1983–1998 Cold Min DT Morbidity Flu-Pneu (56+) No
Breitner, 2014 56 Bavaria, Germany 1990–2006 Heat and cold MDT Mortality CVD (75+) No
Tian, 2012 57 Beijing, China 2000–2011 Heat and cold MDT Mortality Coronary heart disease (65+) No
Lin, 2011 58 4 regions, Taiwan 1994–2007 Heat and cold MDT Mortality CVD, RD (65+) No
O′Neill 2003 59 7 counties, Chicago, USA 1986–1993 Heat and cold Mean ADT Mortality RD, CVD (65+) No
Pan, 1995 60 Taiwan 1981–1991 Heat and cold MDT Mortality IS, IHD, HS (64+) No
Son, 2014 61 8 cities, South Korea 2003–2008 Heat and cold MDT Morbidity Allergy, Asthma, RD, CVD (65+) No
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261A. Bunker et al. / EBioMedicine 6 (2016) 258–268Astrom and colleagues asserts elderly people (65+) are at greater risk
ofmortality andmorbidity during exposure to heatwaves than younger
people (Åström et al., 2011). Because heat and cold waves only contrib-
ute to a small proportion of excess deaths (Gasparrini et al., 2015), we
focused on the association between exposure to non-optimum high
and low temperatures rather than anomalous temperature events on
health. Previous reviews have excluded critical epidemiological studies
with information on the underlying cause of death. Cause-speciﬁc
health impacts of temperature on the elderly have been reported
sporadically, but coherent effort to integrate these has so far been
lacking. Here we present a systematic review and meta-analysis with
quantitative evidence on the effects of high and low ambient tempera-
ture (excluding heat and cold waves) on many cause-speciﬁc mortality
and morbidity outcomes in the elderly.
2. Methods
2.1. Inclusion Criteria
Epidemiological studies reporting an age-stratiﬁed, quantitative
association between temperature and only cause-speciﬁc, elderly
mortality or morbidity (hospitalisation, emergency room admissions,
general practise visits, home visits) outcomes were considered. Time-
series and case-crossover design studies were included because they
produce comparable effect estimates (Basu et al., 2005) for investigating
temperature and mortality/morbidity associations. Only English
language publications were considered.
Temperaturewas theprimaryweather exposure. Indexes combining
variables including temperature, humidity and wind velocity were
considered, providing comparable risk estimates were produced.
Other primary environmental exposures such as air pollution (including
dust) were deemed outside the scope of this review. Heat studies
were deﬁned as those presenting effect estimates per unit increase
above summer or yearly threshold temperatures, or linear effects with
no threshold. Cold studies were those with effect estimates per unit
below awinter or yearly threshold temperature, or no threshold for lin-
ear effects. Studies presenting non-linear risk estimates [study ID 36]
not convertible to a 1 °C change in temperature were considered in
the systematic review, but excluded from the meta-analysis, including
effect estimates given as a comparison between two threshold temper-
atures [study ID 56–61] (study IDs are deﬁned in Table 1). Heat wave
and coldwaveswere excluded because they are unique events with dif-
fering characteristics. To produce robust causal associations explaining
the mechanisms linking exposure and outcome, studies were required
to have analysed a minimum of three consecutive years/seasons of
temperature-health associations. Studies investigating the effects of
medication or binary exposures such as disasters were excluded.
A consistent deﬁnition of the elderly is yet to be applied in academic
and policy discourse. Most deﬁnitions correspond with a retirement age
of 65. Following this convention, we deﬁne elderly as those aged 65+
years with two caveats: to minimise information loss, studies combining
the 65+ age group with slightly younger age groups (50–74, 56+, 55–
69 years) and studies in low-income countries with low life expectancy
where the elderly were deﬁned as 50+ were considered in this review.
2.2. Search Strategy
Two investigators (AB andAV) conducted independent searches using
Medical Subject Headings on the PubMed, Web of Science and Ovid
Medline databases (Supplementary File S1). English language studies
published between 1 January 1975 and 24 July 2015 in peer-reviewed
journals, on the effect of temperature exposure on cause-speciﬁc mortal-
ity or morbidity in the elderly were retrieved. Titles and abstracts were
scanned for ﬁt against the inclusion and exclusion criteria. Full text docu-
ments of candidate studies were integrated into one library and details
corresponding to each publication recorded systematically. The resultsfrom both reviewerswere compared and disagreements resolved by con-
sulting two senior investigators (SH and NH). A consensus was reached
on papers included in the review. Authorswere contacted to obtainmiss-
ing information required for this analysis.
2.3. Data Management and Statistical Analysis
Cause-speciﬁc risk estimates were standardised to percent change
(%) per 1 °C change in temperature. The most statistically signiﬁcant
effect estimate (and when unavailable, the highest effect estimate)
was selected when results were presented for multiple lag days or
thresholds. Unique datasets were created for each cause-speciﬁc
mortality or morbidity disease outcome for heat and cold exposure.
The percent change and 95% conﬁdence interval was transformed into
a beta coefﬁcient (β) and standard error. A random-effects meta-
analysis, which accounts for intra- and inter-city heterogeneity, was con-
ducted. The two-staged analysis included; i) pooling of age-stratiﬁed
risks (i.e. 65–74, 75+) in individual studies to produce one estimate
(65+), ii) meta-analysis of city-speciﬁc estimates, requiring at least
two effect estimates per disease category (indicated here as k N 2).
Heterogeneity was investigated using the I2 statistic, where increas-
ing values (ranging 0–100%) correspond to increasing heterogeneity.
Subgroup analysis was performed to test if i) the risk of mortality or
morbidity increased with age, and ii) pooling age-stratiﬁed effect
estimates into one estimate (i.e. 65–74, 75–84, 85+ years into 65+
years) increased heterogeneity. Further sensitivity analyses explored
changes in risk estimates and/or heterogeneity scores based on lag
days between exposure and outcome, temperature variable, type of
hospital admission, grouping cholesterol and blood pressure-related
cardiovascular outcomes, and control for air pollution in studies of re-
spiratory outcomes. Publication bias was also assessed. All analyses
were carried out using the Meta package v. 4.3–2 in R.
3. Results
The systematic search retrieved 4984mortality papers and 3777mor-
bidity papers. Of the 25mortality and 35morbidity papers that ﬁt the in-
clusion and exclusion criteria, 18mortality and 31morbidity publications
were suitable for meta-analysis (Fig. 1). The characteristics of studies in-
vestigating the effects of high and low temperature on cause-speciﬁc
mortality and morbidity in the elderly are summarised in Table 1 (see
also Supplementary File 2). The locations studied were dispersed across
Europe, Asia, North and South America, but not Africa. We applied the
Köppen–Geiger classiﬁcation (Kottek et al., 2006) to further investigate
geographic spread by ﬁve climate zones; ‘A-Equatorial’, ‘B-Arid’, ‘C-Tem-
perate’, ‘D-Snow’ and ‘E-Polar’ (Fig. 2). Two studies [study IDs 2,39] are lo-
cated in equatorial areas and one [study ID 1] in the arid zone. Clustering
in the snow and temperate zones reﬂect the uneven distribution of study
locations. The duration of the time-series ranged from3 to 26 years. Stud-
ies used various forms of ambient temperature as the exposure. Mean
daily ambient temperaturewas themost common exposure (28 studies).
Apparent temperature (also termed heat index), a combined metric of
temperature and humidity used to gauge human discomfort, was also
common. Diurnal temperature range (DTR) an exposure accounting for
temperature variability; the difference between daily maximum and
minimum temperatures, was applied by six studies [study IDs
4,11,23,27,29,34]. A detailed analysis of exposuremeasures and study de-
sign/statistical modelling are in Supplementary Files 3 and 4.
Cause-speciﬁc mortality and morbidity outcomes in the systematic
review and meta-analysis are reported using the International Classiﬁ-
cation of Disease (ICD 10) nomenclature and hierarchy (Supplementary
File S5). A total of 13 publications were suitable for only the systematic
review, including study IDs 56–61, which present risk estimates
comparing two temperatures (Supplementary Table 2). The risk of
cardiovascular and cerebrovascular outcomes, including cerebral infarc-
tion, cerebral haemorrhage and ischemic heart disease increased with
262 A. Bunker et al. / EBioMedicine 6 (2016) 258–268heat [study IDs 56–61] and cold exposure inmost studies [study IDs 56–
61]. Only Pan, et al. report a 0.73 lower odds of cerebral haemorrhage at
32 versus 28 °C. Respiratory deaths decreased by 2.5% with heat expo-
sure in Chicago, USA at 29 versus 18 °C [study ID 59]. Cold exposure in-
creased the risk of allergy [study ID 61] and respiratory mortality and
morbidity [study IDs 58,59,61]. A non-linear relative risk of mental
health emergency department visits ranging from 1.05 to 1.09 at 25 °C
was observed across three regions of Quebec, Canada [study ID 36].
Studies applying DTR [study IDs 4,11,23,27,29,34], an exposure metric
not comparable to temperature or apparent temperature was included
only in the systematic review. Cardiovascular mortality and morbidity
relative risk increased in all but the 75+; 0.95 (95% CI 0.06–1.84)
[study ID 4], and 65–74 group; 0.99 (0.99–1.0) [study ID 27] per 1 °C
increase in DTR. Heart failure morbidity increased dramatically in
Hong Kong, China [study ID 29]. Interestingly, the risk of respiratory
morbidity (all respiratory, respiratory tract infection) increased with a
1 °C increase in DTR [study IDs 23,27,34], whereas mortality decreased
(Basu et al., 2005). In Taiwan [study ID 27], the 75+ group exhibited
slightly elevated risks per 1 °C increase in DTR for renal; 1.02 (1.0–Fig. 1. Prisma diagram outlining the selection pro1.04) and digestive; 1.04 (1.02–1.05) morbidity compared with the
65+ age group.
We report mortality meta-estimates (where k N 2) for ischemic
heart disease (ICD-10 codes I20–25), all cardiovascular (I00–99), all
cerebrovascular (I60–69), and all respiratory outcomes (J00–99).
Morbidity meta-estimates (k N 2) are presented for ischemic stroke
(I63), intracerebral haemorrhage (I61), myocardial infarction (I21–23),
angina pectoris (I20), heart failure (I50), asthma (J45–46), pneumonia
(J09–18), diabetes mellitus (E10–14), acute renal failure (N17), intesti-
nal infectious (A00–99), heat-related outcomes (E70–90, T66–78 and
R00–99), all cardiovascular (I00–99), all cerebrovascular (I60–69), and
all respiratory outcomes (J00–99). In addition, we present an ‘overall’
estimate for both mortality and morbidity outcomes, an amalgamation
of the subgroups presented by individual studies including the ‘all’ cate-
gory. The frequency count of each disease subgroup in themeta-analysis
is given in Fig. 3. All cardiovascular disease (CVD) and all respiratory
disease (RD) outweighed other mortality subgroups. A greater range of
disease groups were represented by morbidity outcomes, including all
RD and all CVD, followed by cerebral infarction, myocardial infarction,cedure for mortality and morbidity articles.
Fig. 2. Distribution of A) Mortality, and B) Morbidity studies across ﬁve Köppen Geiger climate zones (A–E). Study numbers on the map (ID) are deﬁned in Table 1. Panel A comprises
mortality studies (ID 1–20, 56–60), panel B comprises morbidity studies (ID 21–55, 61). ID 56–61 represent publications with risk estimates as a comparison between two
temperatures. Repeated ID numbers on the map indicates that one study presents estimates for multiple cities.
263A. Bunker et al. / EBioMedicine 6 (2016) 258–268heart failure, all genitourinary disease, intestinal infection and diabetes
mellitus. Threshold temperatures were selected by individual studies
based on study location. Lag times, presented as cumulative or single
day lags describing the delay between exposure and outcome, varied
with high and low temperature. Heat lags were shorter than cold lags,
generally between lag 0–1 to 0–3 days prior to the event. Cold lags
ranged between 0 to 30 days.
We observed a striking increase in the risk of all mortality outcomes,
including cerebrovascular, cardiovascular and respiratory outcomes
(Table 2 and forest plots in Supplementary File 6). The greatest risks
were for heat-induced CVD and RD, and cold-induced RD mortality.
Cerebrovascular (CBD) risks also increased with cold exposure. No
protective effect (risk reduction) was found for any mortality outcome;
only ischemic heart disease risk was statistically insigniﬁcant; 0.45%
(95% CI−0.01–0.91) per 1 °C decrease in temperature. Compared to
the universally elevated mortality risks, temperature-related morbidity
risksweremixed for CBD and CVD outcomes (Table 3 and forest plots in
Supplementary File 6). In warm periods, the risk of intracerebral
haemorrhage, myocardial infarction and all CBD morbidity reduced
per 1 °C increase in temperature. In winter, the risk of morbidity fromangina, heart failure, all CVD, and all CBD reduced per 1 °C decrease in
temperature. Heat exposure led to an increase in RD morbidity
by 2.76% (1.51–4.03). A statistically signiﬁcant increase was noted
for heat-induced diabetes mellitus 1.02% (0.43–1.62) and an even
greater risk for heat-related overall genitourinary morbidity 2.12%
(1.65–2.59). A 1 °C increase in temperature resulted in elevated risks
for overall infectious and heat-related morbidity. The greatest statisti-
cally signiﬁcant risk was associated with pneumonia; 1 °C reduction in
temperature caused a 6.89% (1.20–12.99) increase in morbidity in cold
periods.
We explored temporal patterns of the temperature-outcome
relationship (lags) for all diseases (Supplementary File 7). We pooled
heat effects as a) lag 0, 1 and 0–1, and b) above lag 2, and cold effects
as a) b lag 15 b) N lag 15. The risk for heat-related CVD mortality was
greatest for lag 0–1; 4.15% (3.7–4.59) relative to N lag 2 days; 2.97%
(1.8–4.15). The converse was observed for heat-related CVDmorbidity;
a longer lag was associated with a higher risk of illness 0.27% (0.03–
0.51). The risk of both heat-induced respiratory mortality (5.33%,
3.69–6.99) and morbidity (2.76%, 1.32–4.21) were greater for lag
N2 days. Heat-induced cerebrovascular mortality and morbidity risk
Fig. 3. Number of cause-speciﬁc A) mortality, and B) morbidity outcomes included in the meta-analysis.
264 A. Bunker et al. / EBioMedicine 6 (2016) 258–268estimates were elevated for the shorter lag, 0–1 days. The risks for heat-
related diabetes, infectious, and renal disease morbidity were greater for
the longer lag period of above 2 days.With the exception of cold-induced
respiratory morbidity 6.98% (2.47–11.68, lag b 15 days), low tempera-
tures were associated with a greater risk of mortality and morbidity for
the longer lag period of above 15 days for cardiovascular and respiratory
outcomes.
Publication bias was assessed with funnel plots. The asymmetrical
distribution of study results suggests some level of publication bias in
plots B, C, E, N, P (Supplementary File 8). These plots are characterised
by few studies in the white triangle, showing that smaller, statistically
insigniﬁcant results are missing. The apex of plots B, C, E, N, P are, how-
ever, dominated by studies with large sample sizes and low standard
error, which can skew the plot to indicate publication bias.
Heterogeneity (I2) was high, between 60.8 to 99.2% for mortality
causes and varied from 0 to 98.6% for morbidity outcomes, supporting
our use of a random-effects meta-analysis. Through an age-speciﬁc
analysis, we investigated if the high heterogeneity scores were attribut-
able to grouping risk estimates from multiple age groups. Although I2
reduced drastically in the younger age group (65–74), heterogeneity
remained high for the 75+ age group (between 59.3–94.9%) (Supple-
mentary File 9). Regression model choice appeared to be an important
determinant of heterogeneity. Pooling independent studies resulted in
larger I2 scores than pooling one study applying a consistent modelling
strategy across multiple sites. Risks did not universally increase with
age, as the 65–74 age group exhibited greater heat-induced all RDmor-
bidity, all CBDmortality and cold-induced all RDmortality compared to
the75+age group.We independently groupedheat-induced respirato-
ry hospital admissions and emergency admissions to assess if pooling
these outcomes was a cause of heterogeneity. The results were mixed;
neither the relative risk nor I2 varied greatly for overall RD, although I2
for all RD hospital admissions dropped to 50.7% across 15 city-speciﬁc
hospital admissions [study IDs 28, 37, 39, 44, 45]. We tested if poolingcholesterol and blood pressure-related CVD outcomes altered the
results. We removed the ‘all CVD’ estimates from the ‘overall CVD’
meta-estimate and grouped the remaining diseases as being related to
cholesterol (1), systemic blood pressure (2), or both (3). Only heat-
induced CVD mortality had more than two cholesterol and blood
pressure outcomes, to enable a comparison. Heat-related mortality
was higher for cholesterol 0.06% (−0.35–0.47) than blood pressure
−0.87% (−4.93–3.38). There was very little difference between heat-
induced overall CVD mortality (0.15%, 0.05–0.35), and cholesterol CVD
mortality 0.06% (−0.35–0.47).
Compared with the original risk estimates, controlling for air pollu-
tion caused a decrease in the relative risk in two of the four outcomes;
heat-induced respiratory mortality, and cold-induced respiratory
morbidity. Most of these reductions in relative risk were small to
moderate (less than 2% per 1 °C change in temperature). The statis-
tical signiﬁcance only changed for overall cold-induced morbidity,
where controlling for air pollution reduced the relative risk to
0.83% (−2.53–4.37) per 1 °C decrease in temperature from 4.93%
(1.54–8.44) (Supplementary File 10). There was no consistent
trend across mortality/morbidity, heat/cold studies supporting
unanimous elevated risks for either apparent temperature or air
temperature as the preferred exposure (Supplementary File 11).
4. Discussion
Our systematic review and meta-analysis reveals temperature is
associated with an increase in risk across every cause-speciﬁc mortality
outcome and most morbidity outcomes in the elderly. The dataset
comprises greater than 16 million elderly case events and is to our
knowledge the largest analysis of temperature on cause-speciﬁc out-
comes in a vulnerable group. Relevant publications were identiﬁed in
a comprehensive search and effort was made to obtain pertinent data
not included in the original publications to meta-analyse a robust
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265A. Bunker et al. / EBioMedicine 6 (2016) 258–268sample of city-speciﬁc estimates. CBD, CVD and RD featured high
sample size (n) and number of city-speciﬁc estimates (k). Endocrine,
genitourinary, and infectious disease risks were elevated with heat
exposure, but require further study to increase the statistical power of
the estimates. Age-stratiﬁed data were combined to obtain one effect
per study location using the inverse variance method. This enabled a
fair comparison of effect estimates because the age groups were similar.
By excluding heat and cold wave studies, we show that temperature
exposure in time-series spanning three or more years/seasons is associ-
ated with increased risk for many cause-speciﬁc health outcomes in the
elderly. Adverse heat effects are concerning because an increase in
mean worldwide temperatures from global warming is anticipated
(IPCC, 2013). Future studies might also consider using a time-series of
30+ years to build evidence on climate change-related temperature ef-
fects on cause-speciﬁc health outcomes in the elderly. Inter-study het-
erogeneity (I2) was generally high. Although I2 exceeding 75%
typically indicates considerable heterogeneity, this threshold is likely
more suited for controlled epidemiological study designs. Observational
studies on the temperature-health relationship, however, do not follow
stringent reporting guidelines. A previousmeta-analysis of temperature
effects on cardiorespiratory health also reports I2 scores ranging 89–99%
(Turner et al., 2012). Heterogeneity can be attributed to several factors
including differences in location, exposure variable, modelling, lag
structures, threshold temperatures, adjustment for confounding
variables, and grouping of different morbidity outcomes (hospital,
emergency or general practitioner (GP) visits). It remains unclear,
however, why I2 reduced for hospital admissions, but not emergency
admissions in our sensitivity analysis. Furthermore, inherent differences
among locations including population age structure, access to medical
care, social services for the elderly, housing quality and prevalence of
air conditioning and heating/insulation can also increase I2 (Basu and
Samet, 2002a; Kenny et al., 2010; Medina-Ramon and Schwartz,
2007). Most studies in our meta-analysis are located in the ‘C’ or tem-
perate climate zone; geographic location is unlikely to be the primary
cause of heterogeneity (Turner et al., 2012). Given the physiological
limits to human adaptation and climate sensitivity of local resources
(i.e. crops, ﬁsheries), populations living in regions with more extreme
climates such as Africa are likely to be highly sensitive to shifts in
temperature. There is need for better understanding of how the health
risks vary for such groups. It proved unfeasible to obtain the original
and covariate datasets for the 49 studies included here to run
standardised regressions or test all causes of heterogeneity through
meta-regression.We reason the studiesmeta-analysed here are compa-
rable and produce meaningful results.
Risks were greatest for respiratory mortality and morbidity, with
both heat and cold exposure, and longer lag periods. Heat exposure
could trigger the release of inﬂammatory factors, increase ventilation
and exacerbate chronic obstructive pulmonary disease (White, 2006;
Leon and Helwig, 2010; Malik et al., 1983; Mannino and Mannino,
2011; Anderson et al., 2013), which is highly prevalent in the elderly.
Anderson and colleagues also suggest that a few minutes of inhaling
hot air can trigger adverse airway responses in the elderly, increasing
morbidity (Anderson et al., 2013). Although indoor crowding and/or
reduced ventilation during winter is thought to increase
viral transmission (Hajat and Haines, 2002), alternative biological
mechanisms have been proposed. Inspiration of cold air can cause
bronchoconstriction and airway congestion, triggering asthma
(Giesbrecht, 1995), and increase susceptibility to infection by reducing
mucosal clearing (Eccles, 2002). We conclude that further research is
required to establish aetiological mechanisms for how exposure to
moderate cold and particularly heat cause adverse respiratory
outcomes in the elderly. Sensitivity analysis revealed only a small to
moderate (less than 2% per 1 °C change in temperature) difference in
the relative risk for studies that controlled for air pollution, with the ex-
ception of cold-induced respiratory morbidity. Although controlling for
air pollution is common in studies of temperature on health, evidence
Table 3
Random-effects meta-analytic % change (and 95% conﬁdence interval) for heat and cold related cerebrovascular, cardiovascular, respiratory, endocrine, genitourinary, infectious and heat-related morbidity outcomes.
Heat outcomes correspond to percentage change per 1 °C increase in temperature above a heat threshold in summermonths, across the year or as a linear risk. Cold outcomes correspond to percentage change per 1 °C decrease in temperature below a
threshold in wintermonths, across the year or as a linear risk. Meta-analysis is conductedwhen k (number of city-speciﬁc risk estimates) N2. * indicates a statistically signiﬁcant RR at the 5% level, arrows indicate risk increase or decrease, – indicates
no change in risk. I2 = heterogeneity score. Sample size was not obtainable for the following studies: Hajat 2002 a, Vasconcelos 2013 b, Alessandrini 2011 c, Michelozzi 2009 (65–74 year age group) d, Hopstock 2011 e, Alessandrini 2011 f, Williams
2012 g.
ICD-10 code Cause of morbidity (k N 2) Morbidity heat Morbidity cold
% change (95% CI) % change (95% CI)
Cerebrovascular
I63 Ischemic stroke 0.33(−0.09–0.75) ↑ k = 5, I2 = 84.9%, p = b0.0001, n = 178,487 3.63(−3.94–11.8) ↑ k = 2, I2 = 85.8%, p = 0.008, n = 39,658
I61 Intracerebral haemorrhage −0.66(−2.13–0.84) ↓ k = 2, I2 = 88.6%, p = 0.0031, n = 10,739 1.49(1.04–1.94)* ↑ k = 2, I2 = 0%, p = 0.3908, n = 92,991
I20–I25 All cerebrovascular −0.17(−0.96–0.63) ↓ k = 4, I2 = 46.6%,0.1318, n = 212,616 d −0.46(−1.12–0.2) ↓ k = 8, I2 = 98.6%, p = b0.0001, n = 552,527
I60, I61, I63, I20–I25 Overall 0.08(−0.01–0.17) ↑ k = 12 I2 = 76.9%, p = b0.0001, n = 347,098 d 0.05(−0.37–0.47) ↑ k = 14, I2 = 97.9%, p = b0.0001, n = 733,743
Cardiovascular
I21–I23 Myocardial infarction −0.16(−2.05–1.77) ↓ k = 3, I2 = 73.4%, p = b0.0001, n = 5842 e 0.66(−0.14–1.48) ↑ k = 7, I2 = 93%, p = b0.0001, n = 339,073 b
I20 Angina pectoris NA NA −0.80(−2.21–0.64) ↓ k = 3, I2 = 90.1%, p = b0.0001, n = 331,324
I50 Heart failure NA NA −0.67(−2.15–0.83) ↓ k = 3, I2 = 96.4%, p = b0.0001, n = 457,437
I00–I99 All cardiovascular disease 0.30(−0.12–0.81) ↑ k = 9, I2 = 93.5%, p = b0.0001, n = 929,168 d, f −0.28(−1.39–0.84) ↓ k = 6, I2 = 57.3%, p = b0.0388, n = 4,371,849 a, c
I21–23, I20, I50, I00–I99, I20–I25, I27.9, I70 Overall 0.15(−0.05–0.35) ↑ k = 20, I2 = 97.6%, p = b0.0001, n = 1,015,480 d, e, f 0.00(−0.67–0.66) – k = 19, I2 = 96.6%, p = b0.0001, n = 5,499,683 a, b, c
Respiratory
J45–J46 Asthma NA NA 3.84(−9.38–18.99) ↑ k = 2, I2 = 81.2%, p = 0.0212, n = 3885 a, c
J09–J18 Pneumonia NA NA 6.89(1.20–12.99)* ↑ k = 4, I2 = 94.5%, p = b0.0001, n = 68,968
J00–J99 All respiratory disease 2.76(1.51–4.03)* ↑ k = 20, I2 = 82.5%, p = b0.0001, n = 121,078 2.70(−0.72–6.24) ↑ k = 5, I2 = 91.9%, p = b0.0001, n = 1,267,454 f
J00–J99, J40–J44, J09–J18, J45–46 Overall 1.65(1.09–2.21)* ↑ k = 23, I2 = 81.4%, p = b0.0001, n = 2,530,203 4.93(1.54–8.44)* ↑ k = 13, I2 = 97.1%, p = b0.0001, n = 1,808,820 a, c, f
Endocrine
E10–E14 Diabetes mellitus 1.02(0.43–1.62)* ↑ k = 3, I2 = 25.3%, p = 0.2623, n = 18,393 NA NA
Genitourinary
N17 Acute renal failure 2.12(1.59–2.65)* ↑ k = 2, I2 = 16%, p = 0.2752, n = 26,359 NA NA
E10–E14 Overall 2.12(1.65–2.59)* ↑ k = 4, I2 = 0%, p = 0.4613, n = 26,798 g
Infectious
A00–99 Intestinal infectious 1.00(−0.21–2.22) ↑ k = 2, I2 = 0%, p = 0.05228, n = 6064 NA NA
A00–B99, G00–G05, N70–74, N76 Overall 0.76(−0.43–1.95) ↑ k = 4, I2 = 27.2%, p = 0.2487, n = 148,663 NA NA
Heat
E86 Dehydration 3.12(0.74–5.56)* ↑ k = 2, I2 = 77.7%, p = b0.0001, n = 28,901 NA NA
E86, T67, E70–90, X30 Overall 14.83(8.22–21.84)* ↑ k = 2, I2 = 98.3%, p = b0.0001, n = 29,753 g NA NA
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267A. Bunker et al. / EBioMedicine 6 (2016) 258–268suggests it is indeed important to capture the entire causal effect, ren-
dering adjustment for air pollution unnecessary in most circumstances
(Buckley et al., 2014).
CBD and CVD risks were markedly elevated, but only for mortality.
Heat causes an increase in cardiac output, redistributes blood ﬂow
away from core organs, attenuates vasodilatation and sweat rate, and
increases the potential for thrombosis (Keatinge et al., 1986). These
responses are worsened by the limited thermoregulatory capacity and
high cholesterol levels in the elderly (Keatinge et al., 1986), elevating
cardiovascular strain and the likelihood of acute coronary events.
Furthermore, systems in the body do not act in isolation; infection or in-
ﬂammation of the respiratory systemcan spur growth of atherosclerotic
plaques and promote hypercoagulation, promoting thrombotic events
(Lavallée et al., 2002). Cold exposure can also increase blood pressure,
blood viscosity, systemic inﬂammation and thrombosis (Keatinge
et al., 1984). The observed excess risk of CBD/CVD mortality compared
to CBD/CVD morbidity may be attributable to short lag times where
death occurs rapidly before hospitalisation. The reported cause of
death may therefore be inaccurate, overlooking underlying conditions.
Only a single study [study ID 14] investigated the impact of pre-
existing hypertension on RD in the elderly. Furthermore, death rarely
goes unreported but morbidity not leading to hospitalisation or a GP
visit is likely under-reported. Tomore broadly capture the effect of tem-
perature on morbidity, community-based data, such as from general
practise and home visits should also be used in addition to
hospitalisation data. We identiﬁed only one study that used GP data
[study ID 54]. With the exception of heat-induced CVD mortality, be-
cause only cholesterol-related subgroups existed, we could not deter-
mine whether blood pressure-related risk increased with cold
exposure and cholesterol-related risk increased with heat exposure.
Our pooling strategy (of combining the blood pressure and cholesterol
diseases) was therefore justiﬁed, considering the negligible difference
between heat-induced overall CVD and cholesterol-related risk.
Diabetes and genitourinary morbidity increased with heat and longer
lag periods. Chronic diseases such as diabetes can trigger metabolic,
cardiovascular, neurologic and behavioural dysfunctions that impair ther-
moregulatory responses during heat stress (Kenny et al., 2010). Poor
glucose control and neuropathy attenuate sweating responses in type 2
diabetics (Kenny et al., 2010), which is a concern as obesity and diabetes
rates are projected to increase. Similarly, during heat exposure the diver-
sion of blood from the splanchnic and renal vasculature to the periphery
can stress the renal system(Semenza et al., 1999). In addition to tradition-
al diseases (CBD, CVD, RD) this exposes a need tomore rigorously under-
stand how temperature affects under-represented diseases such as renal,
endocrine andmental outcomes. Addressed in only two studies [study IDs
6,36], data for the temperature effects on elderly mental health are
severely lacking, despite neurological and mental diseases contributing
highly to their burdenof disease (Prince et al., 2015).Moreover, the ability
to sense environmental cues and take preventive action is compromised
(Basu and Samet, 2002b), further endangering elderly peoplewithmental
and neurological illnesses. Few studies investigated temperature impacts
on infectious disease. This bias is likely the result of geographic clustering
of studies in Europe andother afﬂuent countries,where elderly people are
likely to be affected by diseases associatedwith longer life expectancy. To
effectively capture global exposure-response effects, age-speciﬁc analysis
of temperature on cause-speciﬁc mortality or morbidity in populated
equatorial and arid zones are required. We found that the risk of heat-
related outcomes increase with heat exposure. Unfortunately, the lack
of a systematic deﬁnition of heat and cold-related deaths or illnesses is
likely to have led to severe under-reporting of these causes, which are
often considered only when no other cause can be determined.
Some limitationsmust benoted.Wewere unable to extend our anal-
ysis to quantify the attributable burden of risk to high and low ambient
temperature. Only English language publications were considered. We
present all effect estimates as originally reported irrespective of the
magnitude or direction of the risk. We took precautions to excludeheat and cold wave studies, where extreme temperature is likely to
favour increased risk estimates. Regardless of these measures, we
found evidence of positive publication bias.
We identify substantially elevated risks in the elderly for temperature-
induced cerebrovascular, cardiovascular, and respiratory outcomes in
particular. In addition, we ﬁnd heat exposure-associated increases in
diabetes, genitourinary, heat-related and infectious disease morbidity,
all of which are anticipated to grow in importance with climate change
and global ageing.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.ebiom.2016.02.034.
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